Behind the preparations lie the supply agreements for recreational cannabis with all 10 Canadian provinces — a feat accomplished by only two other companies. What might also catch investors' attention is OrganiGram's cooperation with Montreal-based biotechnology company Hyasynth, that experiments with engineered yeast in order to produce cannabinoids outside the natural path.